{
    "eid": "2-s2.0-85047485244",
    "title": "Pharmacological treatments for alleviating agitation in dementia: a systematic review and network meta-analysis",
    "cover-date": "2018-07-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology (medical)",
            "@code": "2736",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "agitation",
        "Alzheimer's disease",
        "dementia",
        "network meta-analysis",
        "pharmacological treatments"
    ],
    "authors": [
        "Khachen Kongpakwattana",
        "Ratree Sawangjit",
        "Itthipol Tawankanjanachot",
        "J. Simon Bell",
        "Sarah N. Hilmer",
        "Nathorn Chaiyakunapruk"
    ],
    "citedby-count": 34,
    "ref-count": 100,
    "ref-list": [
        "Assessment and management of behavioral and psychological symptoms of dementia",
        "Neuropsychiatric symptoms in Alzheimer's disease",
        "Longitudinal course of behavioural and psychological symptoms of dementia: systematic review",
        "Agitated behaviors in the elderly. I. A conceptual review",
        "Patient and caregiver characteristics and nursing home placement in patients with dementia",
        "Neuropsychiatric symptoms and the risk of institutionalization and death: the Aging, Demographics, and Memory Study",
        "Caregiver burden and neuropsychiatric symptoms in older adults with cognitive impairment: the Aging, Demographics, and Memory Study (ADAMS)",
        "The American Psychiatric Association practice guideline on the use of antipsychotics to treat agitation or psychosis in patients with dementia",
        "Investigational drugs for treating agitation in persons with dementia",
        "Pharmacological treatments for neuropsychiatric symptoms of dementia in long-term care: a systematic review",
        "Antidepressants for agitation and psychosis in dementia",
        "Valproate preparations for agitation in dementia",
        "Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone",
        "Haloperidol for agitation in dementia",
        "Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR task force on indirect treatment comparisons good research practices: part 2",
        "Efficacy, acceptability, and tolerability of antipsychotics in treatment-resistant schizophrenia: a network meta-analysis",
        "Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis",
        "Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis",
        "Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis",
        "The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations",
        "Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria",
        "Medication development for agitation and aggression in Alzheimer disease: review and discussion of recent randomized clinical trial design",
        "Chapter 6: searching for studies",
        "Assessing patterns of agitation in Alzheimer's disease patients with the Cohen-Mansfield Agitation Inventory. The Alzheimer's Disease Cooperative Study",
        "Assessing neuropsychiatric symptoms in nursing home patients with dementia: reliability and Reliable Change Index of the Neuropsychiatric Inventory and the Cohen-Mansfield Agitation Inventory",
        "A comparison of the E-BEHAVE-AD, NBRS, and NPI in quantifying clinical improvement in the treatment of agitation and psychosis associated with dementia",
        "Methods to convert continuous outcomes into odds ratios of treatment response and numbers needed to treat: meta-epidemiological study",
        "Imputing response rates from means and standard deviations in meta-analyses",
        "Comparative efficacy and acceptability of first-generation and second-generation antidepressants in the acute treatment of major depression: protocol for a network meta-analysis",
        "An international definition for \u201cnursing home\u201d",
        "A revised tool for assessing risk of bias in randomized trials",
        "Meta-analysis in clinical trials revisited",
        "Network meta-analysis",
        "Consistency and inconsistency in network meta-analysis: model estimation using multivariate meta-regression",
        "Graphical tools for network meta-analysis in STATA",
        "Checking consistency in mixed treatment comparison meta-analysis",
        "Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial",
        "A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis",
        "Visualizing assumptions and results in network meta-analysis: the network graphs package",
        "The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY",
        "The Concise Guide to PHARMACOLOGY 2017/18: Overview",
        "Randomized double-blind placebo-controlled multicenter trial of Yokukansan for neuropsychiatric symptoms in Alzheimer's disease",
        "Effect of dextromethorphan-quinidine on agitation in patients with Alzheimer disease dementia: a randomized clinical trial",
        "Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial",
        "Galantamine versus risperidone for agitation in people with dementia: a randomized, twelve-week, single-center study",
        "Efficacy and tolerability of risperidone, yokukansan, and fluvoxamine for the treatment of behavioral and psychological symptoms of dementia: a blinded, randomized trial",
        "Efficacy of memantine for agitation in Alzheimer's dementia: a randomised double-blind placebo controlled trial",
        "Effects of Yokukansan on behavioral and psychological symptoms of dementia in regular treatment for Alzheimer's disease",
        "Comparison of topiramate and risperidone for the treatment of behavioral disturbances of patients with Alzheimer disease: a double-blind, randomized clinical trial",
        "Effect of oxcarbazepine in the treatment of agitation and aggression in severe dementia",
        "Quetiapine to treat agitation in dementia: a randomized, double-blind, placebo-controlled study",
        "Quetiapine versus risperidone in elderly patients with behavioural and psychological symptoms of dementia: efficacy, safety and cognitive function",
        "A double-blind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia",
        "Donepezil for the treatment of agitation in Alzheimer's disease",
        "Risperidone and rivastigmine and agitated behaviour in severe Alzheimer's disease: a randomised double blind placebo controlled study",
        "Olanzapine versus haloperidol in the treatment of agitation in elderly patients with dementia: results of a randomized controlled double-blind trial",
        "Drug control for agitation behavior of patients with gerontic dementia: magnesium valproate versus risperidone in grouping treatment. [Chinese]",
        "Divalproex sodium in nursing home residents with possible or probable Alzheimer disease complicated by agitation: a randomized, controlled trial",
        "Propranolol for disruptive behaviors in nursing home residents with probable or possible Alzheimer disease: a placebo-controlled study",
        "Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial",
        "A randomized, placebo-controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer's disease in outpatients treated with donepezil",
        "A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia",
        "Placebo-controlled study of divalproex sodium for agitation in dementia",
        "Placebo-controlled study of divalproex sodium for agitation in dementia",
        "Sertraline versus small doses of haloperidol in the treatment of agitated behavior in patients with dementia",
        "A double-blind randomised comparison of risperidone and haloperidol in the treatment of behavioural and psychological symptoms in Chinese dementia patients",
        "Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial",
        "Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial",
        "A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia",
        "A double-blind comparison of trazodone and haloperidol for treatment of agitation in patients with dementia",
        "Pilot study of haloperidol, fluoxetine, and placebo for agitation in Alzheimer's disease",
        "Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses",
        "Quetiapine treatment of psychosis associated with dementia: a double-blind, randomized, placebo-controlled clinical trial",
        "A randomized, double-blind, placebo-controlled study of aripiprazole for the treatment of psychosis in nursing home patients with Alzheimer disease",
        "Frontotemporal dementia: a randomised, controlled trial with trazodone",
        "A placebo-controlled trial of valproate for agitation and aggression in Alzheimer's disease",
        "Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a randomized controlled trial",
        "From admission to death: prevalence and course of pain, agitation, and shortness of breath, and treatment of these symptoms in nursing home residents with dementia",
        "Neuroleptic drugs in dementia: benefits and harm",
        "SSRI antidepressant medications: adverse effects and tolerability",
        "Real-world data on SSRI antidepressant side effects",
        "Antidepressant use and risk of adverse outcomes in older people: population based cohort study",
        "Risk factors associated with falls in older adults with dementia: a systematic review",
        "AVP-786 for the treatment of agitation in dementia of the Alzheimer's type",
        "Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients",
        "Prazosin for the treatment of behavioral symptoms in patients with Alzheimer disease with agitation and aggression",
        "Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease",
        "Quetiapine for agitation or psychosis in patients with dementia and parkinsonism",
        "Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: a 6-week, double-blind, placebo-controlled study",
        "A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bandar Sunway",
            "@id": "60018894",
            "affilname": "Monash University Malaysia",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018894",
            "affiliation-country": "Malaysia"
        },
        {
            "affiliation-city": "Madison",
            "@id": "60032179",
            "affilname": "University of Wisconsin-Madison",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60032179",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pitsanulok",
            "@id": "60022498",
            "affilname": "Naresuan University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022498",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Melbourne",
            "@id": "60019578",
            "affilname": "Monash University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60019578",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Sydney",
            "@id": "60006974",
            "affilname": "Royal North Shore Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006974",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Maha Sarakham",
            "@id": "60002875",
            "affilname": "Mahasarakham University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002875",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}